Dr Reddy's Laboratories Cost of Goods Sold 2010-2024 | RDY
Dr Reddy's Laboratories annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Dr Reddy's Laboratories cost of goods sold for the quarter ending September 30, 2024 was $0.385B, a 12.63% increase year-over-year.
- Dr Reddy's Laboratories cost of goods sold for the twelve months ending September 30, 2024 was $1.456B, a 10.02% increase year-over-year.
- Dr Reddy's Laboratories annual cost of goods sold for 2024 was $1.387B, a 7.02% increase from 2023.
- Dr Reddy's Laboratories annual cost of goods sold for 2023 was $1.296B, a 2.19% decline from 2022.
- Dr Reddy's Laboratories annual cost of goods sold for 2022 was $1.325B, a 11.81% increase from 2021.
Dr Reddy's Laboratories Annual Cost of Goods Sold
(Millions of US $) |
| 2024 |
$1,387 |
| 2023 |
$1,296 |
| 2022 |
$1,325 |
| 2021 |
$1,185 |
| 2020 |
$1,069 |
| 2019 |
$1,018 |
| 2018 |
$1,009 |
| 2017 |
$963 |
| 2016 |
$942 |
| 2015 |
$1,008 |
| 2014 |
$939 |
| 2013 |
$1,021 |
| 2012 |
$853 |
| 2011 |
$773 |
| 2010 |
$755 |
| 2009 |
$ |
Dr Reddy's Laboratories Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-09-30 |
$385 |
| 2024-06-30 |
$365 |
| 2024-03-31 |
$346 |
| 2023-12-31 |
$359 |
| 2023-09-30 |
$342 |
| 2023-06-30 |
$339 |
| 2023-03-31 |
$306 |
| 2022-12-31 |
$337 |
| 2022-09-30 |
$323 |
| 2022-06-30 |
$331 |
| 2022-03-31 |
$316 |
| 2021-12-31 |
$330 |
| 2021-09-30 |
$362 |
| 2021-06-30 |
$316 |
| 2021-03-31 |
$312 |
| 2020-12-31 |
$312 |
| 2020-09-30 |
$305 |
| 2020-06-30 |
$257 |
| 2020-03-31 |
$226 |
| 2019-12-31 |
$284 |
| 2019-09-30 |
$290 |
| 2019-06-30 |
$270 |
| 2019-03-31 |
$286 |
| 2018-12-31 |
$247 |
| 2018-09-30 |
$244 |
| 2018-06-30 |
$241 |
| 2018-03-31 |
$244 |
| 2017-12-31 |
$258 |
| 2017-09-30 |
$258 |
| 2017-06-30 |
$249 |
| 2017-03-31 |
$293 |
| 2016-12-31 |
$223 |
| 2016-09-30 |
$236 |
| 2016-06-30 |
$210 |
| 2016-03-31 |
$230 |
| 2015-12-31 |
$245 |
| 2015-09-30 |
$237 |
| 2015-06-30 |
$230 |
| 2015-03-31 |
$268 |
| 2014-12-31 |
$255 |
| 2014-09-30 |
$246 |
| 2014-06-30 |
$239 |
| 2014-03-31 |
$263 |
| 2013-12-31 |
$225 |
| 2013-09-30 |
$225 |
| 2013-06-30 |
$226 |
| 2013-03-31 |
$301 |
| 2012-12-31 |
$251 |
| 2012-09-30 |
$255 |
| 2012-06-30 |
$214 |
| 2012-03-31 |
$211 |
| 2011-12-31 |
$210 |
| 2011-09-30 |
$229 |
| 2011-06-30 |
$203 |
| 2011-03-31 |
$223 |
| 2010-12-31 |
$191 |
| 2010-09-30 |
$187 |
| 2010-06-30 |
$171 |
| 2010-03-31 |
$205 |
| 2009-12-31 |
$182 |
| 2009-09-30 |
$200 |
| 2009-06-30 |
$168 |
| 2009-03-31 |
$121 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$11.978B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
